Literature DB >> 26920380

Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.

Su-Hyun Kim1, Kichang Kwak2, In Hye Jeong1, Jae-Won Hyun1, Hyo-Jin Jo1, AeRan Joung1, Eun-Seung Yu3, Ji-Hee Kim1, Sang Hyun Lee4, Sooin Yun5, Jungnam Joo5, Dong-Kyun Lee2, Jong-Min Lee2, Ho Jin Kim6.   

Abstract

OBJECTIVE: To compare the frequency and pattern of cognitive impairment (CI) between patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS).
METHODS: A total of 82 NMOSD patients, 58 MS patients, and 45 healthy controls (HCs) underwent a neuropsychological assessment.
RESULTS: CI was observed in 29% of NMOSD and 50% of MS patients (p < 0.001); CI was considered present if a patient scored lower than the fifth percentile compared with HCs in at least three domains. A lower frequency of CI was consistently found when CI was indicated by at least two failed tests (p < 0.001). MS patients performed worse than did NMOSD patients on verbal learning and verbal and visual memory tests. Levels of education and depression and the interval from disease onset to treatment were associated with a negative influence on cognition in patients with NMOSD.
CONCLUSION: CI in patients with NMOSD may be not as common as in patients with MS. MS patients exhibited severe impairment, particularly on learning and memory tests, compared with NMOSD patients. Differential prevalence and patterns of CI between NMOSD and MS patients suggest that the two diseases have different mechanisms of brain injury.
© The Author(s), 2016.

Entities:  

Keywords:  Neuromyelitis optica; cognitive aspects; multiple sclerosis

Mesh:

Year:  2016        PMID: 26920380     DOI: 10.1177/1352458516636246

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  10 in total

Review 1.  Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis.

Authors:  Hao Meng; Jun Xu; Chenling Pan; Jiaxing Cheng; Yue Hu; Yin Hong; Yuehai Shen; Hua Dai
Journal:  J Neurol       Date:  2016-12-01       Impact factor: 4.849

2.  Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder.

Authors:  Elisabet Lopez-Soley; Jose E Meca-Lallana; Sara Llufriu; Yolanda Blanco; Rocío Gómez-Ballesteros; Jorge Maurino; Francisco Pérez-Miralles; Lucía Forero; Carmen Calles; María L Martinez-Gines; Inés Gonzalez-Suarez; Sabas Boyero; Lucía Romero-Pinel; Ángel P Sempere; Virginia Meca-Lallana; Luis Querol; Lucienne Costa-Frossard; Maria Sepulveda; Elisabeth Solana
Journal:  J Pers Med       Date:  2022-05-02

3.  Chronic Cognitive Impairment in AQP4+ NMOSD With Improvement in Cognition on Eculizumab: A Report of Two Cases.

Authors:  Georges Saab; David G Munoz; Dalia L Rotstein
Journal:  Front Neurol       Date:  2022-05-13       Impact factor: 4.086

4.  Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder.

Authors:  Su-Hyun Kim; Eun Young Park; Boram Park; Jae-Won Hyun; Na Young Park; AeRan Joung; Sang Hyun Lee; Ho Jin Kim
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

5.  Cognitive impairment in neuromyelitis optica spectrum disorders: A comparison of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale Revised with the Rao Brief Repeatable Neuropsychological Battery.

Authors:  Juichi Fujimori; Ichiro Nakashima; Toru Baba; Yuko Meguro; Ryo Ogawa; Kazuo Fujihara
Journal:  eNeurologicalSci       Date:  2017-09-21

6.  Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.

Authors:  Hiroki Masuda; Shigeki Hirano; Nobuyoshi Takahashi; Etsuko Hatsugano; Akiyuki Uzawa; Tomohiko Uchida; Ryohei Ohtani; Satoshi Kuwabara; Masahiro Mori
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

7.  Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder.

Authors:  Lingyao Kong; Yanlin Lang; Xiaofei Wang; Jiancheng Wang; Hongxi Chen; Ziyan Shi; Hongyu Zhou
Journal:  Front Neurol       Date:  2022-09-16       Impact factor: 4.086

Review 8.  Differential diagnosis of neuromyelitis optica spectrum disorders.

Authors:  Sung-Min Kim; Seong-Joon Kim; Haeng Jin Lee; Hiroshi Kuroda; Jacqueline Palace; Kazuo Fujihara
Journal:  Ther Adv Neurol Disord       Date:  2017-05-24       Impact factor: 6.570

Review 9.  Cognitive impairment in NMOSD-More questions than answers.

Authors:  Dominika Czarnecka; Magdalena Oset; Iwona Karlińska; Mariusz Stasiołek
Journal:  Brain Behav       Date:  2020-10-06       Impact factor: 2.708

10.  Disrupted structural network of inferomedial temporal regions in relapsing-remitting multiple sclerosis compared with neuromyelitis optica spectrum disorder.

Authors:  Eun Bin Cho; Daegyeom Kim; ByeongChang Jeong; Jong Hwa Shin; Yeon Hak Chung; Sung Tae Kim; Byoung Joon Kim; Cheol E Han; Ju-Hong Min
Journal:  Sci Rep       Date:  2022-03-25       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.